Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$24.4 - $41.3 $62,268 - $105,397
-2,552 Reduced 24.61%
7,819 $284,000
Q2 2022

Aug 12, 2022

BUY
$36.95 - $82.41 $147,467 - $328,898
3,991 Added 62.55%
10,371 $469,000
Q1 2022

May 13, 2022

BUY
$55.7 - $145.79 $213,219 - $558,084
3,828 Added 150.0%
6,380 $485,000
Q4 2021

Feb 11, 2022

BUY
$135.05 - $182.59 $344,647 - $465,969
2,552 New
2,552 $380,000
Q2 2021

Aug 12, 2021

SELL
$134.22 - $202.37 $650,698 - $981,089
-4,848 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$140.25 - $196.86 $679,932 - $954,377
4,848 New
4,848 $877,000
Q4 2020

Feb 12, 2021

SELL
$126.47 - $163.7 $359,048 - $464,744
-2,839 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$87.44 - $125.0 $248,242 - $354,875
2,839 New
2,839 $354,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.51B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Alp Invest Partners B.V. Portfolio

Follow Alp Invest Partners B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alp Invest Partners B.V., based on Form 13F filings with the SEC.

News

Stay updated on Alp Invest Partners B.V. with notifications on news.